Part 6: Detection and Prevention of Foot Problems in Type 2 Diabetes

Diabetes Foot Problems: Other ReferencesAbbott RD, Brand FN, Kannel WB. Epidemiology of some peripheral arterial findings in diabetic menand women: Experiences from the Framingham study. Am J Med 1990;88:376-81.Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabeticperipheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care1997;20:1162-7.Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJM, Holman RR. UKPDS 59: hyperglycaemiaand other potentially modifiable risk factors for peripheral vascular disease in Type 2 diabetes.Diabetes Care 2002;25:894-9.Albert S. Cost-effective management of recalcitrant diabetic foot ulcers. Clinics in Podiatric Medicineand Surgery. 2002; 19: 483-91.Al-Delaimy WK, Merchant AT, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Effect of Type 2diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med2004;116:236-40.Alogna M. CDC diabetes control programs – Overview of diabetes patient education. Diabetes Educ1985;10:32-6,57.Apelqvist J, Larsson J, Agardh C-D. The importance of peripheral pulses, peripheral oedema and localpain for the outcome of diabetic foot ulcers. Diabet Med 1990;7:590-4.Apelqvist J, Larsson J, Agardh C-D. Medical risk factors in diabetic patients with foot ulcers andsevere peripheral vascular disease and their influence on outcome. J Diabetes Complications1992;6:167-74.Apelqvist J, Ragnarson-Tennvall G, Larsson J, Person U. Long-term costs for foot ulcers in diabeticpatients in a multidisciplinary setting. Foot Ankle Int 1995;16:388-94.Ariyo AA, Thach C, Tracy R Cardiovascular Health Study Investigators. Lp(a) lipoprotein, vasculardisease, and mortality in the elderly. N Eng J Med 2003;349:2108-15.Armstrong DG. Three questions can identify ulcer risk. Podiatry Today 1998;5:34-6.Armstrong DG. The 10-g monofilament. The diagnostic divining rod for the diabetic foot? DiabetesCare 2000;23:887.Armstrong DG, Abu-Rumman PL, Nixon BP, Boulton AJM. Continuous activity monitoring in personsat high risk for diabetes-related lower-extremity amputation. J Am Podiatr Med Assoc 2001;91:451-5.Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J FootAnkle Surg 1998;37:460-6.Armstrong DG, Lavery LA. Diabetic foot ulcers: Prevention, diagnosis and classification. Am FamPhysician 1998;57:1325-32.Armstrong DG, Lavery LA, Harkless LB. Treatment-based classification system for assessment andcare of diabetic feet. J Am Podiatr Med Assoc 1996;86:311-6.Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. Thecontribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998;21:855-9.Armstrong DG, Lavery LA, Harkless LB, Van Houtum WH. Amputation and reamputation of thediabetic foot. J Am Podiatr Med Assoc 1997;87:255-9.114